Credit Suisse’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-22,593	Closed	-$194K	–	3332
2018 Q3	$194K	Buy	+22,593	New	+$194K	﹤0.01%	3183
2016 Q2	–	Sell	-188,979	Closed	-$2.74M	–	3881
2016 Q1	$2.74M	Buy	+188,979	New	+$2.74M	﹤0.01%	1764